The National Department of Health reassured the public that SA is not facing antiretroviral (ARV) shortages, even though two suppliers - Barrs and Innovata, both subsidiaries of Avacare Health – are currently entering business rescue. - Times Live (2026).
Spokesperson Foster Mohale said such risks were anticipated and mitigated through diversified procurement, buffer stock, and improved monitoring systems. The tender awarded to multiple suppliers to allow volumes to be shifted if one fails. Provinces currently hold about three months of stock of affected ARVs, with close national and provincial oversight. Contingency measures have been implemented and other suppliers have increased production to maintain continuity.